It was a busy week in the biotech sector with lots of regulatory and pipeline updates. Among bigwigs, Gilead Sciences, Inc.

GSK PLC GSK shares inched up 0.04% to £13.34 Wednesday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100 Index UKX rising 0.05% to 8,199.11. Supported ...

This marks the first case of H5N1 bird flu in the US connected to backyard flock exposure, according to health officials.

On a stop in Lancaster city, Gov. Josh Shapiro said Pennsylvania intends to follow through with its $21 million commitment to ...

The disclosure raises more questions about Yang, 50, who was banned from Britain on national security grounds, and his ...

Bank of America Securities analyst Graham Parry has maintained their bearish stance on GSK stock, giving a Sell rating on December 11.Pick the ...

Pfizer’s financial challenges are offset by growth potential in oncology and strong dividends. Learn why PFE stock is a "Buy" ...

Broad enrollment criteria appear to have scuttled the trial, which was designed to test whether ctDNA could identify patients ...

A pat­ent dis­pute between GSK sub­si­di­ary ViiV Health­care and Colom­bian reg­u­lat­ors is not cur­rently before the Inter­na­tional Centre for Set­tle­ment of Invest­ment Dis­putes in Wash­ing­ton ...

The test used two synovial fluid biomarkers to accurately differentiate osteoarthritis from inflammatory arthritis, but its ...

Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for a ...